References
- Helfand C. Could soaring vaccine prices spark Sovaldi-style payer pushback? Fierce Vaccines 10 luglio 2014. [ cited 2016 May 31]. Available from: http://www.fiercevaccines.com/story/could-soaring-vaccine-prices-sparksovaldi-style-payer-pushback/2014-07-10.
- Curto A, Duranti S, Van de Vooren K, et al. Vaccination planning and vaccine prices in a decentralizing country – Italy. Expert Rev Pharmacoecon Outcomes Res. 2014;4(2):195–202.
- Ministero della Salute. Piano Nazionale Prevenzione Vaccinale 2012-2014. [ cited 2016 May 31]. Available from: www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=466.
- Sole24Ore. Piano nazionale vaccini, ecco il testo all’esame delle Regioni. [2015 Oct 19; cited 2016 May 31]. Available from: http://www.sanita24.ilsole24ore.com/pdf2010/Editrice/ILSOLE24ORE/QUOTIDIANO_SANITA/Online/_Oggetti_Correlati/Documenti/2015/10/20/PNV_BOZZA.pdf?uuid=ACk1kwIB.
- Day M. Italian expert questions need for expanded vaccination schedule. BMJ. 2015;351:h6181. doi:10.1136/bmj.h6181.
- Garattini L, Padula A, Casadei G. Management of vaccinations in Italy: a National survey after healthcare regionalization. J Med Econ. 2011;14(5):527–541.
- Autorità Garante della Concorrenza e del Mercato. Fact-finding investigation IC50 – Vaccines for human use. Executive summary. [2016 May 5; cited 2016 May 31]. Available from: http://www.agcm.it/component/joomdoc/allegati-news/IC50_executivesummary_en.pdf/download.html.
- Garattini L, Van de Vooren K, Freemantle N. Tendering and value-based pricing: lessons from Italy on human papilloma virus vaccines. J R Soc Med. 2014;107:4–5.
- Azienda Sanitaria Locale della Provincia di Bari. Deliberazione Direttore Generale. Bari: ASL Provincia di Bari; 1753/2015.
- Garattini L, Padula A, Da Costa MR. Economic evidence of pneumococcal vaccination in older adults: uncertain modelling or competitive tendering? Pharmacoeconomics. 2016 Mar;34(3):221–224. doi:10.1007/s40273-015-0341-4.
- WHO. Principles and considerations for adding a vaccine to a national immunization programme: from decision to implementation and monitoring. Geneva (Switzerland): World Health Organization; 2014.